Skip to main content
Skip to content
Case File
efta-01522138DOJ Data Set 10Other

EFTA01522138

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01522138
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL- OAP FDG ACCT. For the Period 1/1112 to 1/31/12 Equity Summary Asset Categories US Large Cap Equity 160.064.44 156,814.37 (3,250.07) 9585 Concentrated .3 Other Equity 0.00 5,051.04 5,051.04 3% Total Value $160,064.44 $161,865.41 $1,800.97 98% Beginning Ending Change Current Asset Categories Market Value Market Value In Value Allocation Market Value/Cost Current Period Value Market Value 161.865.41 Tax Cost 146.974.44 Unrealized Gain;Loss 14990.97 Estimated Annual Income 5,407.27 Accrued Dividends 405.99 Yield 3.34% Note- P indicates position adjusted for Pending Trade Activity. Equity Detail COMOIlf arid 6 Other Eqfitif *US Lap Cep EcitNty Equity as a percentage of your portfolio - 98 % Adjusted Tax Cost Unrealized Est Annual Inc Price Quantity Value Original Cost Gain.toss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 002824-10-0 AST 54.15 148.000 8,014.20 7,308.74 705.48 284.16 71.04 3.55% ANALOG DEVICES INC 39.13 176.000 6,886.88 8,011.39 875.49 176.00 2.56% 032854-10-5 ADI JP Morgan Page 4 of 11 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049623 SDNY_GM_00318821 EFTA01522138

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.